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Patientswith prior Ml, including recent Ml (within preceding 2 weeks), were
less likely to have peri-procedural infarctions.
Variable Ml n = 221 No Ml n = 6127 P
PreviousMl so (374A) 2822 (46”/.) 0.00s4
Recent Ml 32 (17%) 1075 (20”/0) 0.0049
No priorMl 136 (74%) 3304 (62%)
PreviousCABG 5S (27%) 669 (15”/6) 0.0001
No priorCABG 154 (73%) 3749 (650A)
Target graft lesion 40 (22%) 365 (6%) 0.0001
Targst native lesion 145 (76%) 5645 (94%)
Corrchsions: Patients with prior CABG undergoing percutaneous inter-
ventions were at high risk for procedural Mls. Interventions on grafts were
much more likely to be associated with Ml as interventions on native lesions.
Strategies directed at preventing pen-procedural Ml in these patients need
to be developed. A histoty of recent Ml was not a significant predictor of peri-
interventional events; in fact, in this sample, patients with prior infarctions
experienced fewer procedural infarctions.
n9937 Omission of Routine ECG and CK-Monitoring
Following Uncomplicated Coronary Angioplasty
L. Pizzulli, W. Kremer, M. Zirbes, W. Jung, B. Luderitz. Depatirnerrt of
CardiobgN UrriversityofBonn, Bonn, Gerrrrany
Thedifferent management of patients (pat) following PTCAinfluences hospital-
costs and in-hoapital stay. It includes often the monitoring of ECG and CK-
Ievels. In a proapectlve study we analyzed the influence of both parameters
on the clinical course after uncomplicated PTCA. We enrolled 600 pat re-
ferred foreleotive intervention. In all pat the ECG and CK were checked pre-,
immediately pa.t-PTCA and after 5 and 24 hours. A total of 98 pat were
excluded due to visible dissections ancflor thrombus. Thus, 502 pat fulfilled
the entry criteria for uncomplicated intervention. They were monitored clin-
ically and angina was assessed as non-present (0), mild and new onset in
comparison to pre-PTCA (l), chest pain requiring nitroglycerin (H)and severe
chest pain (Ill).
Reaulta:
o I II Ill
Angina (n=) 462 20 13 7
re-angio (n =) o 0 10 7
ST-changes (%) 4.5 6.5 7s 100
non-Q-wave-Ml (n=) o 0 3 4
The CK-levels increased from 38 +24 WI (pre-PTCA) to 29 +21 (pest-
PTCA), W *38 (after 5 h) and 47 &86 (after 24 h). A significant increase
occurred only in pat with symptomatic ischemia (11+ Ill). There were no
consequences in asymptomatic pts (0) despite ECG-changes occurring in
4.5%.
Corrc/uaiorr:The routine monitoring of ECG and CK-levels following suc-
cessful PTCA is omitfable since postprocedural therapeutic consequences
depend only on patients symptoms.
n9938 Upright Poeture With a Flexibie Femoral Sheath:Safety and Coet Results from 900 Patiente in the
“Heads Up” Trial
M.W. Krucoff, D.1.Landis, C.L. Green, A.K. Loeffler, E. Eisenstein,
A. Moore, J.E. Tctteng, R.M. Califf, D.B. Mark, K.G. Morris, M.H. Sketch, Jr..
Duke University Medical Centec Durbam, NC, USA, VAMedical Centar,
Durham, NC, USA
Femoral arteriotomy sites area source of added morbidity and cost in PTCR
patients. To assess safety and influence on cost of sitting up with a flexible
woven metal sheath (Arrow-Flex, Arrow) 900 (78%) of all eligible pts under-
going elective PTCR over I year were randomized to upright (head of bed
fjr)9) or supine (head of bed 3rJQ)position, stratified forsheathremoval=me
day (<12 Ma)or nextday(?12 hra).Sheathswere8 Fr in 98%, venous&
arterial in 17%, with Reopro usad in 31%. Costs (50th [25th, 75th %ile] in $)
of sedatives, narcotics, NSAIDS& anti-emetics (MEDS); labs, transfusions,
vascular X-rays, procedures & surgical consults (LAB.IWR), as well as inci-
dence (Y.)of all MAJOR (retro or groin bleed with PRBCS,fistulelaneutysm,
pulse loss) & MINOR (oozing, hematoma, bruit) vascular events from end,of
PTCR to 24 hrs after sheath pull were:
Parametsr <12 HRS suDine Umiaht >12 HRSsuoina Umiaht
#Prs 245 340 107 10s
MEDS 16 (11, 64) 16 (11, 59) 74 (66, 94) 73 (60, S9)
LABSiXR 103 (46, 134) 109 (47, 150) 121 (71, 195) 116 (60, 176)
ALL $$$ 122 (70, 192) 124 (77, 166) 204” (143, 2S5) 197* (135, 257)
MINOR 127 (37”/0) 131 (39%) 57 (53%) 84 (59%)
MAJOR 45 (13%) 45 (130/.) 17 (16°/0) 14 (13%)
*P= o.23 by Wilcoxon Rank Sum Teat
Thus: Upright posture with a flexible sheath was safe, and associated
with a trend to cost reduction in pt management.
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Closure Device in Patients Undergoing PTCA and
Stenting: Single Center Experience
C. Loubeyre, C. Karam, J. Fajadet, C.’Jordan, B. Cassagneau,
J.-P, Laurent, J. Marco. Chrique Pasteur, Toulouse, Franca
In order to assess the safety and the efficacy of a suture mediated closure
of femoral access after PTCA, we carried out a prospective study in 232
patients (pts) from February to June 96. After a preliminary experience with
the device in 237 pts, providing the training period, showing a success rate
of 92%, hematoma in 3.4%, and vascular surgery in 2.1%, we conducted the
prospective study which included 182 males, 50 females, with a mean age of
63+ 10 years (36-84). Stents were implanted in 146 pts (63%). All pts were
fully anticoagulated attimeof sheath removal (mean aPTT:741 sac). Average
bolus heparin dose was 9600 units. In addition to heparin, all pts received
24 to 46 h Ticiopidine + ASA, 31 pts LMWH, and 5 pts c7E3 (ReoPro). Six
operators used Techstar 6F in 47, Techstar 8F in 88, Prostar Plus 8F in 95
and Prostar 9F in 2. Average time to achieve hemostasis was 10 + 4 min
(3-30), Immediate procedural succees was achieved in 212/232 pte (91.4%).
Complications included: hematoma in 15/232 (6.4%), false aneutysm in 5/232
(2.1%), infection in 1/232 (0.4%). These complications needed vascular
repair in 5/232 (2.1%): 3 were performed during the hospital phaee, and 2
were delayed. A mechanical compression was added in 53 pts. Average time
to ambulation was 12 hours (2-48). Mean time to discharge was 1.9 + 1
(l-7) days.
Conclusion: Despite high volume experience, the use of percutaneous
vascular surgery device following corona~ interventions in pts under full
anticoagulation and antiplatelet regimen is associated with vascular compli-
cations in 9% and vascular surgery in 2.1Yoof pts. Average time to ambulation
is obtained 12 h after procedure.
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Percutaneous Coronary Intervention With
Glycoprotein lib/flia Receptor Inhibitor Therapy in
the EPiC Triai
J.C. Blankenship, A.S. Hellkamp, S.L. Demko, F.V.Aguirre, E.J. Topol,
R.M. Califf, for the EPIC Investigators. Gaisirrger A4edica/Centec Danvi//e,
PA, USA
We evaluated predictors of vascular accees cite (VAS) complications (comp)
of percutaneous coronary intervention (PC!) with vs. without the glycoprotein
llb/llla receptor inhibitor abciximab in the EPIC trial. Methods: 2099 patients
undergoing PCI were randomized to placebo vs abciximab bolus vs ab-
ciximab bolu?Jinfusion.Heparin continued after PCI for 12–16 hre; sheaths
were pulled >4 hrs after that. Predictors of VAS bleeding with drop in Hot >
10-12% or VAS surgical repair were identified with multivariate regression
analysis of 25 baseline and procedural variables. Rasu/ts: 18% of patients
had VAS comp. Predictors included in descending importance: abciximab
treatment, higher baseline Hct, longer time in cath lab, lower weight, female
sex (all p < 0.0001); PCI during Ml (p = 0.0005); higher in-lab ACT (p =
0.0027); advanced age (p = 0.0091); and larger sheath size (p = 0.0298).
VAS comp patients stayed longer in hospital post-PCl (median 4 ve 2 days,
p < 0.001). VAS comp rates across sitee ranged from 6% to 29% (median =
17%, interquaItile range 13%-21%). cOf7C/USiOIW: 1: Abciximab caused ex-
cess VAS comp. 2. Factors under operator control contribute to excess VAS
comp (procedure duration, heparin dosing leading to higher ACTS,sheath
size). 3. The wide variation in incidence of VAS comp across participating
centers may reflect differences in patient management. Identification of “best
practices” at centers with low comp rates may decrease overall VAS mmp
rates.
